T45.AX5D is a billable/specific and POA-exempt diagnosis code from the 2026 ICD-10-CM used to classify the following condition: Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter.
Versions
2026
No changes
2025
New code